Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Microarrays & Multiplexing » Somatic Copy Number Changes in Normal Tissues Near Tumors Shed Light on Oncogenic Processes

Somatic Copy Number Changes in Normal Tissues Near Tumors Shed Light on Oncogenic Processes

Nov 05, 2019
|
staff reporter

NEW YORK – Seemingly normal tissue falling next to cancer cells may contain large somatic copy number alterations (sCNAs) that may or may not line up with those found in tumors from the same individual, according to new research from the University of Texas MD Anderson Cancer Center. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

May
05
Featured Webinar

Establishing a Pharmacogenomic Service for Routine Clinical Care

Sponsored by
Illumina

Adverse drug reactions (ADRs) are responsible for around 5 percent of hospital admissions and occur in 6 percent to 15 percent of hospital stays.

What's Popular?

In Microarrays & Multiplexing

  1. GWAS Uncovers Sex-Based Differences in Genetic Origins of Chronic Pain

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.